| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |